Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Track all the latest updates and news of Parabolic Drugs IPO.
October 25, 2024 4:30:00 AM
Following the IPO, the company plans to spend $54 million to advance lead drug candidate SEP-786 through Phase 2 testing in hypoparathyroidism, according to the filing. The company also plans to ...
Published by : MedCity NewsSeptember 27, 2024 12:10:00 AM
Shares of BioAge Labs (BIOA), a biopharmaceutical company focused on obesity drugs, opened 25% above its initial public offering (IPO) price on Thursday. The Richmond, California-based company set ...
Published by : MSNFebruary 28, 2018 1:04:00 PM
“The investigation of Parabolic Drugs and its directors has nothing to do with Ashoka," says university. CBI has filed a case against them and a few others of Parabolic Drugs for allegedly ...
Published by : moneycontrol.comNovember 15, 2024 3:36:00 PM
Investors looking for a growth stock may be tempted to buy this company, but they shouldn't ignore one key factor.
Published by : YahooIPO Listing Detail
Listing Date: Thursday, July 01, 2010
BSE Scrip Code: 533211
NSE Symbol: PARABOLIC
Listing In: 'B' Group of Securities
ISIN: INE618H01016
Issue Price: Rs. 75.00 Per Equity Share
Face Value: Rs. 10.00 Per Equity Share
Parabolic Drugs Ltd IPO allotment status is now available online.
Parabolic Drugs IPO was open on Jun 14, 2010 and closed on Jun 17, 2010. IPO was oversubscribed by 1.04 times (0.4000 times in retail).
Parabolic Drugs Ltd IPO finally subscribed 1.04 times on its closing day. Parabolic Drugs Ltd IPO was open on Jun 14, 2010 and closed today on Jun 17, 2010 for subscription. Parabolic Drugs Ltd has received bids for 2,77,52,400 shares as against issue size of 2,66,66,667 shares.
Oversubscription detail
Qualified Institutional Buyers (QIBs): 1.48 Times
Non Institutional Investors: 1.20 Times
Retail Individual Investors (RIIs): 0.40 Times
Employee: 0.11 Times
Total: 1.04 Times
Parabolic Drugs Limited is entering in the capital markets with an initial public offering, IPO of Rs. 200 Crore. The price band for the issue has not been decided yet.
Incorporated in 1996, Parabolic Drugs Limited is in the business of manufacturing Active Pharmaceutical Ingredients (API's) and API intermediates. APIs, also known as 'bulk drugs' or 'bulk actives' are the principal ingredient used in making finished dosages in the form of capsules, tablets, liquid, or other forms of dosage, with the addition of other APIs or inactive ingredients.
The issue opens on Jun 14, 2010, and closes for subscription on Jun 17, 2010. The equity shares of the company are proposed to be listed on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).
The Parabolic Drugs IPO is proposed to open on June 14, 2010. The IPO application ends on June 17, 2010.
Retail investors can apply in the retail or non-institutional investor category from June 14, 2010 to June 17, 2010. The Parabolic Drugs IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Parabolic Drugs IPO will open for subscription on June 14, 2010. The public issue will close on June 17, 2010.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
